In response to WFH guidelines for the management of haemophilia, 3rd edition: Is there a difference between extended-half-life FVIII products or not?

Erik Berntorp; Snejana Krassova; Louis Aledort

doi:10.1111/hae.14407

In response to WFH guidelines for the management of haemophilia, 3^rd edition: Is there a difference between extended-half-life FVIII products or not?

Erik Berntorp, Snejana Krassova, Louis Aledort

Clinical Coagulation, Malmö

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e762-e764
Journal	Haemophilia
Volume	27
Issue number	6
DOIs	https://doi.org/10.1111/hae.14407
Publication status	Published - 2021 Nov 1

Subject classification (UKÄ)

Hematology

Access to Document

10.1111/hae.14407Licence: CC BY-NC-ND

Cite this

@article{e2f372cf42dd458495891235a45468df,

title = "In response to WFH guidelines for the management of haemophilia, 3rd edition: Is there a difference between extended-half-life FVIII products or not?",

author = "Erik Berntorp and Snejana Krassova and Louis Aledort",

year = "2021",

month = nov,

day = "1",

doi = "10.1111/hae.14407",

language = "English",

volume = "27",

pages = "e762--e764",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - In response to WFH guidelines for the management of haemophilia, 3rd edition

T2 - Is there a difference between extended-half-life FVIII products or not?

AU - Berntorp, Erik

AU - Krassova, Snejana

AU - Aledort, Louis

PY - 2021/11/1

Y1 - 2021/11/1

U2 - 10.1111/hae.14407

DO - 10.1111/hae.14407

M3 - Letter

C2 - 34498318

AN - SCOPUS:85114493982

VL - 27

SP - e762-e764

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 6

ER -